Source: Eur Respir Monogr 2015; 67: 147-160
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
Eusebi Chiner, José N. Sancho-Chust, Ferran Barbé. Specific diagnosis and clinical pathways in at-risk populations. Eur Respir Monogr 2015; 67: 147-160

Member's Comments

No comment yet.

Related content which might interest you: Differences in the clinical manifestation and diagnosis of TB in children and adults Source: International Congress 2014 – PG20 Global evaluation of tuberculosis from children to adults Year: 2014 Identification and clinical management of LTBI in children versus adults Source: International Congress 2014 – PG20 Global evaluation of tuberculosis from children to adults Year: 2014 Early diagnosis of COPD in a high-risk population using spirometric screening in general practice Source: Annual Congress 2011 - Respiratory epidemiology: methods, definitions and phenotypes Year: 2011 A critical evaluation of the relevance of different asthma phenotypes for clinical practice Source: Annual Congress 2008 - A step-change in asthma. The Lancet/ERS symposium Year: 2008 The clinical current of tuberculosis in patients with different genetic markers Source: Eur Respir J 2006; 28: Suppl. 50, 14s Year: 2006 Transcriptional biomarkers for predicting development of tuberculosis: progress and clinical considerations Source: Eur Respir J, 55 (3) 1901957; 10.1183/13993003.01957-2019 Year: 2020 The dynamics of TB antibodies and antigens in adolescents with different types of clinical TB and polyresistance Source: Annual Congress 2007 - Difficult tuberculosis cases I Year: 2007 Different clinical phenotypes of CLAD: diagnosis and outcomes Source: International Congress 2015 – When chronic inflammation drives fibrosis: a lesson from lung transplantation Year: 2015 The clinical features and treatment of cases with MDR TB of adolescents Source: Annual Congress 2007 - Specific problems in caring for multidrug-resistant tuberculosis and tuberculosis/HIV cases Year: 2007 Critical aspects concerning TB diagnosis in children Source: Eur Respir J 2001; 18: Suppl. 33, 361s Year: 2001 T-cell biomarkers for diagnosis of tuberculosis: candidate evaluation by a simple whole blood assay for clinical translation Source: Eur Respir J, 51 (3) 1800153; 10.1183/13993003.00153-2018 Year: 2018 Antibody and host inflammatory biomarker combinations as diagnostic tools for TB disease Source: International Congress 2017 – Update on TB: latest news Year: 2017 Application of biomarkers and patient characteristics to personalize asthma treatment for children Source: International Congress 2016 – Deep phenotyping to improve treatment outcomes in paediatric asthma Year: 2016 Novel biomarker more strongly associated with tuberculosis treatment outcome than conventional or genotypic methods Source: International Congress 2015 – Science and biomarkers in TB Year: 2015 Towards individualised medicine for airways disease: identifying clinical phenotype groups Source: Eur Respir J 2012; 39: 1033-1034 Year: 2012 Characterisation of clinical phenotypes is mandatory for the development of new drugs Source: Research Seminar 2014 - Human translational medicine: a key bridge for the development of new drugs for severe asthma, COPD and ILD Year: 2014 The peculiarities of detecting TB in risk groups and identification of high-risk groups in TB control in Ukraine Source: Eur Respir J 2005; 26: Suppl. 49, 196s Year: 2005 Clinical characteristics and treatment outcomes of tuberculosis in the elderly Source: Annual Congress 2012 - Non-tuberculous and tuberculous mycobacterial infections: from epidemiology to clinical findings Year: 2012